Libivirumab

Modify Date: 2024-07-29 14:56:30

Libivirumab structure	Common Name	Libivirumab
	CAS Number	569658-79-3	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Libivirumab

Libivirumab (17.1.41) is a humanized anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively[1].

Name	Libivirumab

Description	Libivirumab (17.1.41) is a humanized anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV
In Vitro	Libivirumab (0-500 ng/mL) shows neutralization activity in HepG2-NTCP cells with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively[1].
References	[1]. Wang Q, et al. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. Cell Host Microbe. 2020 Aug 12;28(2):335-349.e6.

No Any Chemical & Physical Properties